• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
JAT 4.44% 43.0¢

JATCORP LIMITED - Announcements

Jatcorp Limited is a producer of supplementary food products, plant-based products and... Jatcorp Limited is a producer of supplementary food products, plant-based products and dairy food products. The Company specializes in cow, goat, and camel milk powder-based formulations for infants through to seniors. The Company’s brands include Neurio, Jinvigorate, IONE, Moroka and Poupin. Neurio offers a range of products focused on supporting the health of people of all ages, from babies to seniors, through its range of nutritional milk powder formulations and other products. Jinvigorate offers Jinvigorate Platinum Immune Support and Diabetic Formula. IONE is suitable for those who want to reduce calorie and fat intake, as well as those with diabetes and hyperlipidemia who want to control their diet. Its Moroka products include Moroka Platinum Formulated Milk Powder with Lactoferrin+igG and Moroka Formulated Milk Powder with Lactoferrin. Its Poupin product is Poupin Silky Brightening Serum, is a revitalizing and restoring serum made with natural herbal extracts. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

JAT Details of Company Address06/09/19
JAT Sunnya - New China contractsPRICE SENSITIVE22/03/19
JAT Orient International - Official visit and product orderPRICE SENSITIVE20/03/19
JAT Reinstatement to Official QuotationPRICE SENSITIVE04/03/19
JAT Half Yearly Report and AccountsPRICE SENSITIVE01/03/19
JAT Suspension from Official QuotationPRICE SENSITIVE01/03/19
JAT Jatenergy creates joints venture manufacturing operation28/02/19
JAT Response to ASX QueryPRICE SENSITIVE27/02/19
JAT Sole agency - Japan and Korea25/02/19
JAT Appendix 3B - options conversion06/02/19
JAT JAT signs MOU with Sinopharm31/01/19
JAT Final Director's Interest Notice - Crimmins29/01/19
JAT Director resignation - Crimmins25/01/19
JAT Appendix 4C - quarterlyPRICE SENSITIVE25/01/19
JAT Proposed Buyback of Error Shares21/01/19
JAT Joint Company Secretary Appointment - Stedwell08/01/19
JAT Amended App 3B07/01/19
JAT Prospectus application form24/12/18
JAT Prospectus24/12/18
JAT Appendix 3B24/12/18
JAT Results of Meeting21/12/18
JAT Ocker Products Sales Agreement06/12/18
JAT Results of Meeting21/11/18
JAT Presentation to 2018 AGM21/11/18
JAT Response to ASX Appendix 4C QueryPRICE SENSITIVE19/11/18
JAT Notice of General Meeting/Proxy Form16/11/18
JAT Appointment of Managing Director15/11/18
JAT Proposed private placementPRICE SENSITIVE12/11/18
JAT Response to ASX Price QueryPRICE SENSITIVE12/11/18
JAT Memorandum for Purchase with Shanghai Dragon08/11/18
JAT MOU - Shanghai Bios Medical Nutrition Technology Ltd08/11/18
JAT Guangzhou Eastern Bridge Purchase MemorandumPRICE SENSITIVE07/11/18
JAT Strategic Co-operation Agreement with Ocker Products Pty Ltd29/10/18
JAT Amended Appendix 3B26/10/18
JAT Appendix 3B25/10/18
JAT Appendix 3B17/10/18
JAT Notice of Annual General Meeting/Proxy Form17/10/18
JAT Appendix 4C - quarterlyPRICE SENSITIVE16/10/18
JAT Reinstatement to Official QuotationPRICE SENSITIVE11/10/18
JAT Results of Meeting10/10/18
JAT Appendix 4G10/10/18
JAT Annual Report to shareholders10/10/18
JAT Details of Company Address09/10/18
JAT ASX Market Release - SuspensionPRICE SENSITIVE01/10/18
JAT Late release of 2018 Financial Report28/09/18
JAT Product manufactured, AA agreement terminatedPRICE SENSITIVE28/09/18
JAT ProspectusPRICE SENSITIVE07/09/18
JAT Distribution agreement with Sinopharm07/09/18
JAT Notice of General Meeting/Proxy Form06/09/18
JAT New China E-Commerce Law05/09/18
JAT Amended Preliminary Final ReportPRICE SENSITIVE03/09/18
JAT Preliminary Final ReportPRICE SENSITIVE31/08/18
JAT Presentation to investors and customers28/08/18
JAT Clarification of Response to ASX Query on 9 August 2018PRICE SENSITIVE24/08/18
JAT Appendix 3B24/08/18
JAT Initial Director's Interest Notice - Crowley23/08/18
JAT Chairman and CFO appointment23/08/18
JAT Market updatePRICE SENSITIVE15/08/18
JAT Change of Director's Interest Notice - Yao10/08/18
JAT Change of Director's Interest Notice - Amended10/08/18
JAT Change of Director's Interest Notice - Crimmins10/08/18
JAT Appendix 3B10/08/18
JAT Distribution Agreement with Healthy One Co10/08/18
JAT Response to ASX QueryPRICE SENSITIVE09/08/18
JAT Clarification of Green Forest distribution agreements09/08/18
JAT NCA - Cessation of Receivership07/08/18
JAT GOLDEN KOALA ENTERS INTO A SUPPLY AGREEMENTPRICE SENSITIVE03/08/18
JAT Clarification regarding the status of Mr Xipeng Li30/07/18
JAT Appointment of Non-Executive Chairman and Managing Director27/07/18
JAT Appendix 4C - quarterlyPRICE SENSITIVE26/07/18
JAT Results of Meeting18/07/18
JAT NEURIO Lactoferrin to sell through Woolworths TMall Flagship18/07/18
JAT Launch of NEURIO products on Xiaohongshu13/07/18
JAT JAT at Shanghai Children's Products Expo10/07/18
JAT JD Global approves the sale of Neurio productsPRICE SENSITIVE04/07/18
JAT Presentation to Investors and Brokers02/07/18
JAT Golden Koala Sales and CFDA approval update29/06/18
JAT NCA update29/06/18
JAT Distribution agreement with Cyclone E-CommercePRICE SENSITIVE26/06/18
JAT Huibao Distribution Agreement and First Sales OrderPRICE SENSITIVE22/06/18
JAT China Sales Update20/06/18
JAT First order received from Shanghai Dragon CorporationPRICE SENSITIVE18/06/18
JAT Acquisition of Sunnya Pty LimitedPRICE SENSITIVE13/06/18
JAT Notice of General Meeting/Proxy Form12/06/18
JAT Trading HaltPRICE SENSITIVE08/06/18
JAT Private placementPRICE SENSITIVE04/06/18
JAT JAT to open retail store in ChinaPRICE SENSITIVE30/05/18
JAT Change in substantial holding - Zhao29/05/18
JAT Change in substantial holding - Li28/05/18
JAT Green Forest AcquisitionPRICE SENSITIVE24/05/18
JAT Change of Director's Interest Notice - Li23/05/18
JAT Change of Director's Interest Notice - Yao23/05/18
JAT Change of Director's Interest Notice Crimmins23/05/18
JAT Appendix 3B23/05/18
JAT Trading HaltPRICE SENSITIVE22/05/18
JAT Results of Meeting11/05/18
JAT Golden Koala participation in China expo03/05/18
JAT Appendix 4C - quarterlyPRICE SENSITIVE27/04/18
JAT Details of Company Address20/04/18
JAT Business update - Chinese salesPRICE SENSITIVE12/04/18
JAT Details of Company Address
06/09/19
JAT Sunnya - New China contracts
22/03/19PRICE SENSITIVE
JAT Orient International - Official visit and product order
20/03/19PRICE SENSITIVE
JAT Reinstatement to Official Quotation
04/03/19PRICE SENSITIVE
JAT Half Yearly Report and Accounts
01/03/19PRICE SENSITIVE
JAT Suspension from Official Quotation
01/03/19PRICE SENSITIVE
JAT Jatenergy creates joints venture manufacturing operation
28/02/19
JAT Response to ASX Query
27/02/19PRICE SENSITIVE
JAT Sole agency - Japan and Korea
25/02/19
JAT Appendix 3B - options conversion
06/02/19
JAT JAT signs MOU with Sinopharm
31/01/19
JAT Final Director's Interest Notice - Crimmins
29/01/19
JAT Director resignation - Crimmins
25/01/19
JAT Appendix 4C - quarterly
25/01/19PRICE SENSITIVE
JAT Proposed Buyback of Error Shares
21/01/19
JAT Joint Company Secretary Appointment - Stedwell
08/01/19
JAT Amended App 3B
07/01/19
JAT Prospectus application form
24/12/18
JAT Prospectus
24/12/18
JAT Appendix 3B
24/12/18
JAT Results of Meeting
21/12/18
JAT Ocker Products Sales Agreement
06/12/18
JAT Results of Meeting
21/11/18
JAT Presentation to 2018 AGM
21/11/18
JAT Response to ASX Appendix 4C Query
19/11/18PRICE SENSITIVE
JAT Notice of General Meeting/Proxy Form
16/11/18
JAT Appointment of Managing Director
15/11/18
JAT Proposed private placement
12/11/18PRICE SENSITIVE
JAT Response to ASX Price Query
12/11/18PRICE SENSITIVE
JAT Memorandum for Purchase with Shanghai Dragon
08/11/18
JAT MOU - Shanghai Bios Medical Nutrition Technology Ltd
08/11/18
JAT Guangzhou Eastern Bridge Purchase Memorandum
07/11/18PRICE SENSITIVE
JAT Strategic Co-operation Agreement with Ocker Products Pty Ltd
29/10/18
JAT Amended Appendix 3B
26/10/18
JAT Appendix 3B
25/10/18
JAT Appendix 3B
17/10/18
JAT Notice of Annual General Meeting/Proxy Form
17/10/18
JAT Appendix 4C - quarterly
16/10/18PRICE SENSITIVE
JAT Reinstatement to Official Quotation
11/10/18PRICE SENSITIVE
JAT Results of Meeting
10/10/18
JAT Appendix 4G
10/10/18
JAT Annual Report to shareholders
10/10/18
JAT Details of Company Address
09/10/18
JAT ASX Market Release - Suspension
01/10/18PRICE SENSITIVE
JAT Late release of 2018 Financial Report
28/09/18
JAT Product manufactured, AA agreement terminated
28/09/18PRICE SENSITIVE
JAT Prospectus
07/09/18PRICE SENSITIVE
JAT Distribution agreement with Sinopharm
07/09/18
JAT Notice of General Meeting/Proxy Form
06/09/18
JAT New China E-Commerce Law
05/09/18
JAT Amended Preliminary Final Report
03/09/18PRICE SENSITIVE
JAT Preliminary Final Report
31/08/18PRICE SENSITIVE
JAT Presentation to investors and customers
28/08/18
JAT Clarification of Response to ASX Query on 9 August 2018
24/08/18PRICE SENSITIVE
JAT Appendix 3B
24/08/18
JAT Initial Director's Interest Notice - Crowley
23/08/18
JAT Chairman and CFO appointment
23/08/18
JAT Market update
15/08/18PRICE SENSITIVE
JAT Change of Director's Interest Notice - Yao
10/08/18
JAT Change of Director's Interest Notice - Amended
10/08/18
JAT Change of Director's Interest Notice - Crimmins
10/08/18
JAT Appendix 3B
10/08/18
JAT Distribution Agreement with Healthy One Co
10/08/18
JAT Response to ASX Query
09/08/18PRICE SENSITIVE
JAT Clarification of Green Forest distribution agreements
09/08/18
JAT NCA - Cessation of Receivership
07/08/18
JAT GOLDEN KOALA ENTERS INTO A SUPPLY AGREEMENT
03/08/18PRICE SENSITIVE
JAT Clarification regarding the status of Mr Xipeng Li
30/07/18
JAT Appointment of Non-Executive Chairman and Managing Director
27/07/18
JAT Appendix 4C - quarterly
26/07/18PRICE SENSITIVE
JAT Results of Meeting
18/07/18
JAT NEURIO Lactoferrin to sell through Woolworths TMall Flagship
18/07/18
JAT Launch of NEURIO products on Xiaohongshu
13/07/18
JAT JAT at Shanghai Children's Products Expo
10/07/18
JAT JD Global approves the sale of Neurio products
04/07/18PRICE SENSITIVE
JAT Presentation to Investors and Brokers
02/07/18
JAT Golden Koala Sales and CFDA approval update
29/06/18
JAT NCA update
29/06/18
JAT Distribution agreement with Cyclone E-Commerce
26/06/18PRICE SENSITIVE
JAT Huibao Distribution Agreement and First Sales Order
22/06/18PRICE SENSITIVE
JAT China Sales Update
20/06/18
JAT First order received from Shanghai Dragon Corporation
18/06/18PRICE SENSITIVE
JAT Acquisition of Sunnya Pty Limited
13/06/18PRICE SENSITIVE
JAT Notice of General Meeting/Proxy Form
12/06/18
JAT Trading Halt
08/06/18PRICE SENSITIVE
JAT Private placement
04/06/18PRICE SENSITIVE
JAT JAT to open retail store in China
30/05/18PRICE SENSITIVE
JAT Change in substantial holding - Zhao
29/05/18
JAT Change in substantial holding - Li
28/05/18
JAT Green Forest Acquisition
24/05/18PRICE SENSITIVE
JAT Change of Director's Interest Notice - Li
23/05/18
JAT Change of Director's Interest Notice - Yao
23/05/18
JAT Change of Director's Interest Notice Crimmins
23/05/18
JAT Appendix 3B
23/05/18
JAT Trading Halt
22/05/18PRICE SENSITIVE
JAT Results of Meeting
11/05/18
JAT Golden Koala participation in China expo
03/05/18
JAT Appendix 4C - quarterly
27/04/18PRICE SENSITIVE
JAT Details of Company Address
20/04/18
JAT Business update - Chinese sales
12/04/18PRICE SENSITIVE
(20min delay)
Last
43.0¢
Change
-0.020(4.44%)
Mkt cap ! $58.28M
Open High Low Value Volume
43.5¢ 43.5¢ 42.5¢ $31.64K 73.78K

Buyers (Bids)

No. Vol. Price($)
3 47262 42.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 29500 1
View Market Depth
Last trade - 14.31pm 22/11/2024 (20 minute delay) ?
JAT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.